Abstract:Cryptosporidium parvum is a highly prevalent zoonotic and anthroponotic protozoan parasite that causes a diarrheal syndrome in children and neonatal livestock, culminating in growth retardation and mortalities. Despite the high prevalence of C. parvum, there are no fully effective and safe drugs for treating infections, and there is no vaccine. We have previously reported that the bacterial-like C. parvum lactate dehydrogenase (CpLDH) enzyme is essential for survival, virulence and growth of C. parvum in vitro and in vivo. In the present study, we screened compound libraries and identified inhibitors against the enzymatic activity of recombinant CpLDH protein in vitro. We tested the inhibitors for anti-Cryptosporidium effect using in vitro infection assays of HCT-8 cells monolayers and identified compounds NSC158011 and NSC10447 that inhibited the proliferation of intracellular C. parvum in vitro, with IC50 values of 14.88 and 72.65 μM, respectively. At doses tolerable in mice, we found that both NSC158011 and NSC10447 consistently significantly reduced the shedding of C. parvum oocysts in infected immunocompromised mice's feces, and prevented intestinal villous atrophy as well as mucosal erosion due to C. parvum. Together, our findings have unveiled promising anti-Cryptosporidium drug candidates that can be explored further for the development of the much needed novel therapeutic agents against C. parvum infections.Cryptosporidium parvum is a protozoan parasite that can cause a life-threatening gastrointestinal disease in children and in immunocompromised adults. The only approved drug for treatment of Cryptosporidium infections in humans is nitazoxanide, but it is not effective in immunocompromised individuals or in children with malnutrition. C. parvum possesses a unique lactate dehydrogenase (CpLDH) enzyme that it uses for generating metabolic energy (ATP) via the glycolytic pathway to fuel its growth and proliferation in the host. We have identified novel inhibitors for the enzymatic activity of CpLDH. Further, we have demonstrated that two of the CpLDH inhibitors effectively block the growth, proliferation and pathogenicity of C. parvum at tolerable doses in immunocompromised mice. Together, our findings have unveiled novel CpLDH inhibitors that can be explored for the development of efficacious therapeutic drugs against C. parvum infections.

Protocol for the cryopreservation of Cryptosporidium isolates using enteroids

An Efficient Method for Viable Cryopreservation of Hookworms and Other Gastrointestinal Nematodes in the Laboratory

A PROPOSED DESIGN FOR THE CRYOPRESERVATION OF INTACT AND ADHERENT HUMAN EMBRYONIC STEM CELL COLONIES

Effects of Cryoprotectants and Storage Conditions on the Survivial and Biocontrol-activity of Freeze-dried Rhodosporidium paludigenum

Cryogenic enrichment of Plasmodium falciparum gametocytes from spiked whole blood

A pumpless and tubeless microfluidic device enables extended in vitro development of Cryptosporidium parvum

In vitro cultivation methods for coccidian parasite research

Genomic and virulence analysis of in vitro cultured Cryptosporidium parvum

A cryopreservation protocol for ex situ conservation of terrestrial orchids using asymbiotic primary and secondary (adventitious) protocorms

Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.

Cryopreservation of two species of the multicellular volvocine green algal genus Astrephomene

Emerging therapeutic avenues against Cryptosporidium: A comprehensive review

High-Throughput Cryopreservation of Plant Cell Cultures for Functional Genomics

Robust and effective methodologies for cryopreservation and DNA extraction from anaerobic gut fungi

Cryopreservation method for Drosophila melanogaster embryos

A simple method of DNA extraction for Eimeria species

FBS-based cryoprotective compositions for effective cryopreservation of gut microbiota and key intestinal microorganisms

Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum

Comparative efficacy and safety of anti-cryptosporidial agents: an in vitro study on nitazoxanide, halofuginone lactate, KDU731, and paromomycin against Cryptosporidium parvum

Critical evaluation of current isolation, detection and genotyping methods of Cryptosporidium species and future direction

A Simple Cryopreservation Method for Efficient Isolation of Live Cells from Dead Animals